Reaction
Splenic Rupture reporting signals
As of the last recalculation, Splenic Rupture appears in 1,620 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is FILGRASTIM (PRR 16.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Filgrastim | 48 | 16.9 | 16.9 |
| Dabigatran Etexilate Mesylate | 87 | 16.2 | 16.2 |
| Dabigatran Etexilate | 89 | 15.5 | 15.5 |
| Apixaban | 74 | 14.8 | 14.9 |
| Heparin Sodium | 15 | 14.1 | 14.1 |
| Rivaroxaban | 174 | 11.9 | 11.9 |
| Clopidogrel Bisulfate | 88 | 11.6 | 11.6 |
| Fondaparinux Sodium | 7 | 11.2 | 11.2 |
| Rifampicin | 8 | 10.2 | 10.2 |
| Ibrutinib | 61 | 10.0 | 10.0 |
| Basiliximab | 9 | 9.9 | 9.9 |
| Hydroxyurea | 16 | 9.8 | 9.8 |
| Pyrazinamide | 7 | 9.6 | 9.6 |
| Alteplase | 9 | 7.7 | 7.7 |
| Bleomycin Sulfate | 6 | 7.5 | 7.5 |
| Pegfilgrastim | 53 | 7.1 | 7.1 |
| Acalabrutinib | 6 | 6.4 | 6.4 |
| Ticagrelor | 13 | 5.3 | 5.3 |
| Azacitidine | 12 | 5.2 | 5.2 |
| Ruxolitinib | 28 | 5.1 | 5.1 |
| Velpatasvir And Sofosbuvir | 5 | 5.0 | 5.0 |